Premium
Excitotoxic loss of post‐synaptic sites is distinct temporally and mechanistically from neuronal death
Author(s) -
Waataja Jonathan J.,
Kim Hee Jung,
Roloff Alan M.,
Thayer Stanley A.
Publication year - 2008
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2007.04973.x
Subject(s) - neuroscience , biology
Dendritic degeneration and loss of synaptic proteins are early events correlated with functional decline in neurodegenerative disease. The temporal and mechanistic relationship between synapse loss and cell death, however, remains unclear. We used confocal microscopy and image processing to count post‐synaptic sites on rat hippocampal neurons by expressing post‐synaptic density protein 95 fused to green fluorescent protein. Fluorescent puncta co‐localized with neurotransmitter release sites, NMDA‐induced Ca 2+ increases and NMDA receptor immunoreactivity. During excitotoxic neurodegeneration, synaptic sites were lost and synaptic transmission impaired. These changes were mediated by NMDA receptors and required Ca 2+ ‐dependent activation of the proteasome pathway. Tracking synapses from the same cell following brief neurotoxic insult revealed transient loss followed by recovery. The time‐course, concentration‐dependence and mechanism for loss of post‐synaptic sites were distinct from those leading to cell death. Cells expressing p14ARF, which inhibits ubiquitination of post‐synaptic density protein 95 and prevents loss of synaptic sites, displayed an increased sensitivity to glutamate‐induced cell death. Thus, excitotoxic synapse loss may be a disease‐modifying process rather than an obligatory step leading to cell death. These results demonstrate the importance of assessing synaptic function independent of neuronal survival during neurodegeneration and indicate that this approach will be useful for identifying toxins that degrade synaptic connections and for screening for agents that protect synaptic function.